Merck divests direct holding in Moderna

Wednesday, 02. December 2020 13:19

American multinational pharmaceutical company Merck & Co. said on Wednesday it decided to divest its direct holding in US biotechnology company Moderna in the first half of the fourth quarter.

The company added it will probably have a small fourth-quarter gain, which will be shown as "other income expense, net" (OIE).

Merck and Moderna both confirmed they will continue to collaborate on the development of cancer vaccines.

Related Links: Merck KGaA
Breaking the News / TF